Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rifampicin-associated pseudomembranous colitis.

A Nakajima1, S Yajima, T Shirakura

  • 1Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Journal of Gastroenterology
|April 25, 2000
PubMed
Summary

This case study supports a link between rifampicin, an anti-tuberculosis drug, and pseudomembranous colitis. Treatment involved stopping the drug and using lactic acid bacteria, avoiding antibiotics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiphospholipid syndrome with complete abdominal aorta occlusion and chondritis.

Modern rheumatology·2014
Same author

Does "conversion chemotherapy" really improve survival in metastatic colorectal cancer patients with liver-limited disease?

World journal of surgery·2013
Same author

Diagnosis of biliary cystadenoma by peroral video cholangioscopy.

Endoscopy·2013
Same author

Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort.

Scandinavian journal of rheumatology·2013
Same author

Expression of the G72/G30 gene in transgenic mice induces behavioral changes.

Molecular psychiatry·2013
Same author

Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance.

Diabetologia·2012

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Pharmacology

Background:

  • Liver cirrhosis patients undergoing anti-tuberculosis therapy are susceptible to gastrointestinal complications.
  • The association between rifampicin and pseudomembranous colitis remains debated in medical literature.

Observation:

  • A patient with liver cirrhosis developed pseudomembranous colitis during treatment with rifampicin and isoniazid.
  • Initial colonoscopy showed subtle mucosal changes; pseudomembranes became evident days later.

Findings:

  • The case suggests a potential association between rifampicin use and the development of pseudomembranous colitis.
  • Successful management was achieved by discontinuing anti-tuberculosis agents and administering lactic acid bacteria, without resorting to vancomycin or metronidazole.

Related Experiment Videos

Implications:

  • This case highlights the importance of considering drug-induced colitis in patients on rifampicin, especially those with underlying conditions like liver cirrhosis.
  • Alternative treatment strategies for pseudomembranous colitis, including probiotics, may be effective and avoid broad-spectrum antibiotics.